A systematic review and meta-analysis of randomised trials of the Tyrosine Kinase Inhibitors (TKI) Erlotinib and Gefitinib as second line treatment for patients with advanced non small cell lung cancer (NSCLC)
收藏DataCite Commons2020-08-03 更新2026-05-07 收录
下载链接：
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013006449
下载链接
链接失效反馈官方服务：
资源简介：
Systematic review protocol registration
提供机构：
Centre for Reviews and Dissemination - CRD
创建时间：
2015-08-04
